Ortho-Substituted Benzofused Macrocyclic Lactams as Zinc Metalloprotease Inhibitors
Authors:
- R D GhaiRGR D Ghai
- R. D. GhaiRGR. D. Ghai
- 1 February 1997
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (4) , 495-505
Abstract
The design and preparation of ortho-substituted benzofused macrocyclic lactams are described. The benzofused macrocyclic lactams were designed as neutral endopeptidase 24.11 (NEP) inhibitors. Docking studies were carried out in a model of thermolysin (TLN) using the MACROMODEL and QXP modeling programs to select suitable ring sizes. These studies predicted that the 11-, 12-, and 13-membered ring macrocyclic lactams would be active in both enzymes TLN and NEP. Good predictability of experimental results, within this series, of binding to thermolysin and to a lesser extent to NEP was observed. A visual comparison, docked at the active site of TLN, is presented for thiorphan, a 10-membered ring macrocycle and an 11-membered ring benzofused macrocyclic lactam. Potent inhibition of both NEP and thermolysin was obtained. The 11-membered ring macrocycle 25a is the most potent inhibitor from this series of compounds (TLN IC50 = 68 nM; NEP IC50 = 0.9 nM). The effects of prodrug 44b administered at 10 mg/kg po on plasma atrial natriuretic peptide (ANP) levels in conscious rats was greater than 200% over a 4 h period.Keywords
This publication has 23 references indexed in Scilit:
- Isolation and characterization of a new atrial peptide-degrading enzyme from bovine kidneyBiochemical and Biophysical Research Communications, 1991
- Mechanisms Involved in the Development of Tolerance to NitrovasodilatorsJournal of Cardiovascular Pharmacology, 1991
- Mechanisms of atrial natriuretic factor-induced vasodilationPharmacology & Therapeutics, 1990
- Respective roles of kallikrein and endopeptidase 24.11 in the metabolic pathway of atrial natriuretic peptide in the ratBiochemical Journal, 1990
- Renal and Depressor Effects of SQ 29,072, a Neutral Endopeptidase Inhibitor, in Conscious Hypertensive RatsJournal of Cardiovascular Pharmacology, 1990
- Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.Proceedings of the National Academy of Sciences, 1989
- Low-dose infusion of atrial natriuretic factor in mild essential hypertension.Circulation, 1989
- UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diureticBiochemical and Biophysical Research Communications, 1989
- Thiorphan, an Inhibitor of Endopeptidase 24.11, Potentiates the Natriuretic Activity of Atrial Natriuretic PeptideJournal of Cardiovascular Pharmacology, 1989
- Carboxyalkyl dipeptides with atrial natriuretic factor potentiating and antihypertensive activityJournal of Medicinal Chemistry, 1989